B12 deficiency after gastric sleeve surgery is one of the most common nutritional complications following sleeve gastrectomy, and without lifelong supplementation, it can lead to serious haematological and neurological harm. The procedure removes up to 80% of the stomach, reducing the parietal cells responsible for producing intrinsic factor — the protein essential for vitamin B12 absorption. This guide explains why the risk arises, how to recognise symptoms, what monitoring is recommended on the NHS, and which supplementation options are available, helping patients and clinicians manage this preventable but potentially irreversible condition effectively.

Why Gastric Sleeve Surgery Increases the Risk of B12 Deficiency

Sleeve gastrectomy removes up to 80% of the stomach, reducing parietal cells and intrinsic factor production, which impairs B12 absorption alongside reduced gastric acid secretion and lower dietary intake.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves removing approximately 75–80% of the stomach, leaving a narrow, tube-shaped pouch. Whilst this procedure does not bypass the small intestine in the way a gastric bypass does, it significantly alters the physiology of digestion in ways that can compromise vitamin B12 absorption.

Vitamin B12 absorption is a complex, multi-step process. In the stomach, hydrochloric acid and pepsin release B12 from food proteins. Crucially, parietal cells in the stomach lining produce a protein called intrinsic factor, which binds to B12 and enables its absorption in the terminal ileum. Following sleeve gastrectomy, the substantial reduction in stomach volume means fewer parietal cells are available, leading to a reduction in intrinsic factor production — though the degree varies between individuals and intrinsic factor production does not cease entirely. Reduced gastric acid secretion further impairs the initial release of B12 from dietary protein.

Accelerated gastric emptying, which can occur after sleeve gastrectomy, may allow less time for B12 extraction and binding, though this is considered a secondary mechanism. Reduced overall food intake — a deliberate outcome of the surgery — also limits the total amount of B12 consumed through diet. Additionally, medications commonly used alongside or after bariatric surgery, such as proton pump inhibitors (PPIs) and metformin, can independently reduce B12 absorption and may necessitate closer monitoring.

For these reasons, B12 deficiency is a commonly reported nutritional deficiency following gastric sleeve surgery, with studies and BOMSS guidance indicating that without appropriate supplementation, a significant proportion of patients will develop suboptimal B12 levels within one to two years post-operatively. Awareness of this risk is essential for both patients and their healthcare teams from the outset.

Recognising the Symptoms of B12 Deficiency After Bariatric Surgery

B12 deficiency causes megaloblastic anaemia and potentially irreversible neurological damage; symptoms include fatigue, tingling, numbness, balance problems, and cognitive changes, which can occur even without anaemia.

Vitamin B12 plays a fundamental role in red blood cell formation, neurological function, and DNA synthesis. When levels fall below the normal range, the consequences can affect multiple body systems, and symptoms may develop gradually — sometimes over months or years — making early recognition particularly important for post-bariatric patients.

Haematological symptoms arise because B12 deficiency impairs red blood cell maturation, leading to megaloblastic anaemia. Patients may experience:

• Persistent fatigue and weakness

• Breathlessness on exertion

• Pallor or a slightly yellowish tinge to the skin

• Heart palpitations

Neurological symptoms are of particular clinical concern, as nerve damage caused by prolonged B12 deficiency can be irreversible if not treated promptly. These include:

• Tingling, numbness, or a 'pins and needles' sensation in the hands and feet

• Difficulty with balance and coordination

• Muscle weakness

• Memory problems, difficulty concentrating, or 'brain fog'

• Mood changes, including low mood or irritability

Important: New or worsening neurological symptoms — such as paraesthesia, gait disturbance, or cognitive change — should be treated as urgent. Patients experiencing these symptoms should seek same-day clinical assessment. Prompt parenteral (intramuscular) B12 treatment is recommended in such cases, in line with BSH guidance, to prevent further or irreversible neurological injury.

It is worth noting that neurological symptoms can occur even in the absence of anaemia, meaning a normal full blood count does not rule out clinically significant B12 deficiency. This is particularly relevant in post-sleeve patients who may be taking iron supplements or eating a relatively varied diet.

Other symptoms can include a sore, inflamed tongue (glossitis), mouth ulcers, and general malaise. Because many of these symptoms overlap with other post-operative complaints — such as fatigue from dietary restriction or iron deficiency — B12 deficiency can sometimes be overlooked. Any new or persistent neurological or haematological symptoms following gastric sleeve surgery should prompt timely investigation.

How B12 Deficiency Is Diagnosed and Monitored on the NHS

Diagnosis is primarily via serum B12 blood testing, with BOMSS recommending routine monitoring at 3, 6, and 12 months post-operatively and annually thereafter; clinical symptoms must always be considered alongside laboratory values.

In the UK, diagnosis of B12 deficiency is primarily made through blood testing. The standard initial investigation is a serum vitamin B12 level, typically measured as part of a broader nutritional blood panel. NHS laboratories generally define deficiency as a serum B12 below approximately 148 pmol/L (equivalent to roughly 200 ng/L or pg/mL), though reference ranges vary between laboratories and results should always be interpreted in the context of local ranges and the patient's clinical presentation. Levels in the borderline range warrant careful clinical assessment alongside symptoms.

Serum B12 alone has recognised limitations and does not always accurately reflect tissue-level B12 status. Where clinical suspicion remains high despite a normal serum B12, additional markers may be requested, including:

• Holotranscobalamin (active B12) — a more specific marker of B12 status, available in some UK laboratories as an alternative or confirmatory test

• Methylmalonic acid (MMA) — elevated in functional B12 deficiency; note that MMA is not universally available on the NHS and can also be raised in renal impairment

• Homocysteine — raised in both B12 and folate deficiency; similarly not universally available and has multiple causes

• Full blood count — to identify macrocytosis or megaloblastic changes

• Blood film — to assess red blood cell morphology

NICE CKS guidance and the British Society for Haematology (BSH) recommend that clinical symptoms should always be considered alongside laboratory values, particularly in high-risk groups such as post-bariatric surgery patients.

Following gastric sleeve surgery, BOMSS guidelines recommend routine nutritional blood monitoring at regular intervals — typically at three months, six months, and twelve months post-operatively, and then annually thereafter as a minimum. These checks usually encompass B12, folate, iron studies, vitamin D, calcium, and a full blood count. Patients should ensure they are registered with a GP who is aware of their surgical history and should attend all recommended follow-up appointments, as early detection of deficiency allows for timely intervention before irreversible complications develop.

Recommended B12 Supplementation Following Gastric Sleeve Surgery

Lifelong B12 supplementation is recommended after sleeve gastrectomy; options include high-dose oral cyanocobalamin (1,000 mcg daily) or intramuscular hydroxocobalamin injections, with IM injections preferred for confirmed deficiency or neurological symptoms.

Given the well-established risk of B12 deficiency after sleeve gastrectomy, lifelong supplementation is widely recommended by bariatric surgery teams across the UK. BOMSS nutritional guidelines advise that all patients undergoing sleeve gastrectomy or gastric bypass should commence B12 supplementation post-operatively and continue indefinitely. (Practice may differ for gastric band procedures, where the absorption mechanism is less affected; patients should follow the advice of their own bariatric team.)

Because intrinsic factor production is reduced after surgery, the standard oral route of B12 absorption — which relies on intrinsic factor — is less reliable. For this reason, high-dose oral supplementation or alternative delivery routes are preferred:

• High-dose oral cyanocobalamin tablets (typically 1,000 micrograms daily) are the standard oral option in the UK. At high doses, a small proportion of B12 is absorbed passively through the gut lining without requiring intrinsic factor, which is sufficient to maintain adequate levels in many patients. Evidence from a Cochrane review suggests that high-dose oral therapy can be as effective as intramuscular treatment for many individuals.

• Sublingual preparations dissolve under the tongue and are absorbed via passive diffusion through the oral mucosa, similarly bypassing the need for intrinsic factor. They are a practical alternative for patients who find tablets difficult to tolerate, though current evidence does not clearly demonstrate superiority over standard high-dose oral tablets.

• Intramuscular (IM) injections of hydroxocobalamin are the most reliable method of ensuring adequate B12 levels, particularly in patients with confirmed deficiency or neurological symptoms. In the UK, hydroxocobalamin 1 mg/mL solution for injection is available on NHS prescription. Per BNF and BSH guidance:

• For confirmed deficiency without neurological involvement: 1 mg IM on alternate days for two weeks, then 1 mg every two to three months for maintenance.
• For confirmed deficiency with neurological involvement: 1 mg IM on alternate days until no further improvement, then 1 mg every two months — urgent initiation is essential to prevent irreversible nerve damage.

Patients should not self-adjust their supplementation regimen without guidance from their GP or bariatric team. The appropriate form and dose may need to be reviewed over time based on blood test results and clinical response. Chewable or liquid formulations are often better tolerated in the early post-operative period when swallowing tablets may be uncomfortable.

If you experience any side effects from hydroxocobalamin injections — such as injection site reactions, headache, or feeling unwell — report these to your GP. Suspected adverse drug reactions can also be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Dietary Sources of B12 and Their Limitations After Surgery

Diet alone cannot reliably prevent B12 deficiency after sleeve gastrectomy because reduced intrinsic factor and gastric acid impair absorption of food-derived B12, regardless of dietary intake.

Vitamin B12 is found almost exclusively in animal-derived foods, making dietary intake an important consideration — though one with significant limitations following gastric sleeve surgery. Understanding which foods are richest in B12 can help patients make informed dietary choices, even though supplementation remains essential.

Good dietary sources of B12 include:

• Meat, particularly beef, lamb, and offal such as liver

• Fish and shellfish, including salmon, sardines, tuna, and clams

• Dairy products such as milk, cheese, and yoghurt

• Eggs (particularly the yolk)

• Some fortified foods, including certain breakfast cereals, plant-based milks, and nutritional yeast — always check the label, as not all products in these categories are fortified with B12, and the amount of B12 added varies between brands

Following sleeve gastrectomy, several factors limit the practical contribution of diet to B12 status. Firstly, reduced stomach capacity means patients eat considerably smaller portions, limiting total B12 intake. Secondly, many patients experience food intolerances or aversions post-operatively — red meat and certain fish are commonly reported as difficult to tolerate in the early months after surgery. Thirdly, and most critically, even if B12-rich foods are consumed, the reduction in intrinsic factor and gastric acid means that the B12 present in food cannot be efficiently absorbed.

For patients following a vegetarian or vegan diet, the risk of B12 deficiency is compounded further, as plant-based foods contain no naturally occurring B12. These individuals should discuss their dietary pattern explicitly with their bariatric dietitian to ensure supplementation is appropriately tailored.

Whilst a nutritious, varied diet remains important for overall health and recovery after bariatric surgery, it should be clearly understood that diet alone cannot reliably prevent B12 deficiency following sleeve gastrectomy. Supplementation is not optional — it is a clinical necessity, as reinforced by BOMSS and NHS guidance.

When to Seek Medical Advice and Long-Term Nutritional Follow-Up

Patients should seek same-day assessment for new neurological symptoms such as paraesthesia or gait disturbance, and should attend annual blood tests as a minimum to monitor their full nutritional profile per BOMSS guidance.

Long-term nutritional follow-up is a cornerstone of safe post-bariatric care, and patients who have undergone gastric sleeve surgery should regard ongoing monitoring not as optional, but as an integral part of their surgical outcome. NICE guidance on obesity management (CG189/QS127) and BOMSS recommendations both emphasise the importance of structured, lifelong follow-up for bariatric patients.

Patients should contact their GP or bariatric team promptly if they experience any of the following:

• New or worsening tingling, numbness, or weakness in the limbs

• Difficulty with balance, coordination, or memory

• Unexplained fatigue, breathlessness, or palpitations

• A sore or swollen tongue, or persistent mouth ulcers

• Any concern that they have missed supplementation for a prolonged period

• Symptoms that suggest anaemia, such as pallor or dizziness

New or worsening neurological symptoms — such as paraesthesia, gait disturbance, or cognitive change — warrant same-day assessment. Prompt parenteral B12 treatment should be initiated without delay in such cases, in line with BSH guidance, to minimise the risk of permanent neurological damage.

An important note on folate: if B12 deficiency is suspected, folate deficiency should not be corrected in isolation before B12 status has been assessed and treated, as doing so can precipitate or worsen neurological complications.

Beyond B12, post-sleeve patients are at risk of multiple nutritional deficiencies, including iron, vitamin D, calcium, folate, zinc, and thiamine. Annual blood tests — at minimum — are recommended to monitor the full nutritional profile, in line with BOMSS guidance. Patients should be registered with a GP who is aware of their surgical history and should ideally have access to a specialist bariatric dietitian for ongoing dietary guidance.

If follow-up has lapsed — which is not uncommon several years after surgery — patients are encouraged to re-engage with their GP to arrange a nutritional review and, where appropriate, re-referral to the original bariatric unit or a local specialist service. It is never too late to address deficiencies, and early intervention significantly reduces the risk of long-term complications. Carrying a record of your surgical history and current supplementation regimen is advisable when attending any new healthcare appointment.

Frequently Asked Questions